Page last updated: 2024-11-02

pioglitazone and Diabetes Mellitus, Type 1

pioglitazone has been researched along with Diabetes Mellitus, Type 1 in 24 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research Excerpts

Excerpt	Relevance	Reference
"Emerging studies suggest a possible increased risk of bladder cancer with pioglitazone therapy."	8.88	Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis. ( Lu, Y; Shen, Z; Xu, C; Zhong, S; Zhu, Z, 2012)
"To determine whether the addition of the thiazoladinedione, pioglitazone, to standard therapy improves metabolic control in adolescents with type 1 diabetes (T1D) and clinical evidence of insulin resistance."	5.12	Pioglitazone as adjunctive therapy in adolescents with type 1 diabetes. ( Cummings, EA; Daneman, D; Hamilton, JK; Zdravkovic, V, 2006)
"Emerging studies suggest a possible increased risk of bladder cancer with pioglitazone therapy."	4.88	Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis. ( Lu, Y; Shen, Z; Xu, C; Zhong, S; Zhu, Z, 2012)
" We investigated the effect of pioglitazone, a thiazolidinedione compound, on the development of multiple low-dose streptozotocin (MLDS)-induced autoimmune diabetes in mice."	3.70	Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes. ( Ando, H; Kobayashi, K; Nagai, Y; Nohara, E; Takamura, T; Yamashita, H, 1999)
"However, the rate of progression to SPIDDM with the use of insulin-sensitizing agents is unknown."	2.76	Pioglitazone may accelerate disease course of slowly progressive type 1 diabetes. ( Katsuki, T; Oikawa, Y; Okubo, Y; Shigihara, T; Shimada, A; Yamada, Y, 2011)
"Cryptococcosis is an opportunistic infection caused by Cryptococcus neoformans that typically presents in immunocompromised patients, most commonly in those with human immunodeficiency virus (HIV) infection."	1.40	Disseminated cryptococcosis in a diabetic patient. ( Khatu, S; Poojary, S, 2014)
"Seventy-three female non-obese diabetic (NOD)/Lt mice aged 4 weeks were randomly divided into 3 groups, control group (n = 25, fed with regular diet), low dosage pioglitazone group (n = 23, pioglitazone of the concentration of 0."	1.32	[Preventive effects of pioglitazone on diabetes and relevant mechanisms, experimental study on non-obese diabetic mice]. ( He, L; Jiang, TJ; Li, X; Luo, JH; Pei, JH; Zhou, ZG, 2004)

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (8.33)	18.2507
2000's	7 (29.17)	29.6817
2010's	12 (50.00)	24.3611
2020's	3 (12.50)	2.80

Authors

Authors	Studies
Cinakova, A	1
Krenek, P	1
Klimas, J	1
Kralova, E	1
Lo, C	1
Toyama, T	1
Oshima, M	1
Jun, M	1
Chin, KL	1
Hawley, CM	1
Zoungas, S	1
Gbr, AA	1
Abdel Baky, NA	1
Mohamed, EA	1
Zaky, HS	1
Abdelhamid, AM	1
Abdelaziz, RR	1
Salem, HAA	1
Kumar, R	1
Pilania, RK	1
Bhatia, A	1
Dayal, D	1
Tafuri, KS	1
Godil, MA	1
Lane, AH	1
Wilson, TA	1
Poojary, S	1
Khatu, S	1
DeGeeter, M	1
Williamson, B	1
Oei, E	1
Samad, N	1
Visser, A	1
Chowdhury, TA	1
Fan, SL	1
Cusi, K	1
Sanyal, AJ	1
Zhang, S	1
Hoogwerf, BJ	1
Chang, AM	1
Jacober, SJ	1
Bue-Valleskey, JM	1
Higdon, AN	1
Bastyr, EJ	1
Haupt, A	1
Hartman, ML	1
Kawano, Y	1
Irie, J	1
Nakatani, H	1
Yamada, S	1
Eto, K	1
Tumenbayar, B	1
Nagashima, S	1
Tazoe, F	1
Miyamoto, M	1
Takahashi, M	1
Ando, A	1
Okada, K	1
Yagyu, H	1
Ishibashi, S	1
Kurra, S	1
Siris, E	1
Shimada, A	2
Shigihara, T	2
Okubo, Y	2
Katsuki, T	1
Yamada, Y	1
Oikawa, Y	2
Zhu, Z	1
Shen, Z	1
Lu, Y	1
Zhong, S	1
Xu, C	1
Johnson, JA	1
Colmers, IN	1
Pei, JH	1
Zhou, ZG	1
Luo, JH	1
Jiang, TJ	1
Li, X	1
He, L	1
Hida, K	1
Wada, J	1
Eguchi, J	1
Zhang, H	1
Baba, M	1
Seida, A	1
Hashimoto, I	1
Okada, T	1
Yasuhara, A	1
Nakatsuka, A	1
Shikata, K	1
Hourai, S	1
Futami, J	1
Watanabe, E	1
Matsuki, Y	1
Hiramatsu, R	1
Akagi, S	1
Makino, H	1
Kanwar, YS	1
Kanazawa, Y	1
Zdravkovic, V	1
Hamilton, JK	1
Daneman, D	1
Cummings, EA	1
Bhat, R	1
Bhansali, A	1
Bhadada, S	1
Sialy, R	1
Sheffield, CA	1
Kane, MP	1
Busch, RS	1
Matsuhisa, M	1
Shi, ZQ	1
Wan, C	1
Lekas, M	1
Rodgers, CD	1
Giacca, A	1
Kawamori, R	1
Vranic, M	1
Takamura, T	1
Ando, H	1
Nagai, Y	1
Yamashita, H	1
Nohara, E	1
Kobayashi, K	1

Clinical Trials (14)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Efficacy and Safety of Empagliflozin Compared With Linagliptin in New-onset Diabetes Mellitus After Kidney Transplantation[NCT03642184]	Phase 4	6 participants (Actual)	Interventional	2018-07-14	Terminated (stopped due to Difficult in enrolling suitable participants)
Influence of Pioglitazone for Renal Transplant Function in Diabetics - a Double Blind Randomised Placebo Controlled Cross Over Study[NCT00507494]	Phase 3	0 participants	Interventional	2007-07-31	Completed
Treat-To-Target Trial of Continuous Subcutaneous, Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation (SAPT-NODAT)[NCT01680185]	Phase 3	85 participants (Actual)	Interventional	2012-08-31	Completed
A Randomized Controlled Trial of Pioglitazone on Insulin Resistance, Insulin Secretion and Atherosclerosis in Renal Allograft Recipients Without History of Diabetes[NCT00598013]		83 participants (Actual)	Interventional	2004-11-30	Completed
Vildagliptin in New Onset Diabetes After Transplantation - A Double-blind, Randomized, Placebo-controlled Trial[NCT00980356]	Phase 2	32 participants (Actual)	Interventional	2009-09-30	Completed
Intravenous Insulin Protocol in Diabetes and Renal Transplantation Study[NCT00609986]		104 participants (Actual)	Interventional	2007-07-31	Completed
The Effect of Sitagliptin Treatment on Glucose Metabolism and Endothelial Function in Renal Transplant Recipients - JANUVIA-08[NCT00740363]	Phase 4	25 participants (Actual)	Interventional	2008-09-30	Completed
Treat-to-target Trial of Basal Insulin in Post-transplant Hyperglycemia (TIP): Efficacy and Safety of a Novel Protocol in Renal Transplant Recipients Receiving a Tacrolimus-based Immunosuppression[NCT00830297]	Phase 2	50 participants (Actual)	Interventional	2009-01-31	Completed
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Post-transplantation Diabetes Mellitus[NCT03157414]	Phase 4	49 participants (Actual)	Interventional	2016-11-07	Completed
Randomized Controlled Trial Comparing the Metabolic Efficiency of Allogeneic Pancreatic Islet Transplantation to Intensive Insulin Therapy for the Treatment of Type 1 Diabetes[NCT01148680]	Phase 3	50 participants (Actual)	Interventional	2010-06-30	Completed
Glucose Control in Pre-Diabetic Renal Transplant Patients: Efficacy and Safety of Vildagliptin and Pioglitazone[NCT01346254]	Phase 2	51 participants (Actual)	Interventional	2009-12-31	Completed
Randomized Study of the Impact of Peri-operative Glucose Control on Short Term Renal Allograft Function After Transplantation[NCT01643382]		60 participants (Actual)	Interventional	2012-08-31	Completed
Cyclophosphamide in the Treatment of Panniculitis Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes[NCT03936829]		10 participants (Anticipated)	Interventional	2019-04-28	Recruiting
Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus[NCT00545857]	Phase 1	15 participants (Actual)	Interventional	2002-06-30	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Acute/Active Rejection

Grades IA through III and antibody immediate rejection, either A (immediate or hyperacute) or B (delayed or accelerated acute) were diagnosed and classified based on renal allograft biopsies according to the Banff 97 Working Classification of Renal Allograph Pathology. (NCT00609986)
Timeframe: 30 months

Intervention	participants (Number)
Intensive	9
Control	2

Delayed Graft Function

Need for dialysis in the first week post-transplant in a patient who required dialysis pre-transplantation or day-10 post-transplant creatinine concentration above 2.5 mg/dl. (NCT00609986)
Timeframe: 10 days

Intervention	participants (Number)
Intensive	8
Control	12

Severe Hyperglycemia

Blood glucose greater than 350 mg/dl. (NCT00609986)
Timeframe: 30 months

Intervention	participants (Number)
Intensive	5
Control	12

Severe Hypoglycemia

Blood glucose less than 40 mg/dl (NCT00609986)
Timeframe: 30 months

Intervention	participants (Number)
Intensive	7
Control	2

Incidence of Poor Graft Function After Kidney Transplant

Our primary endpoint will be poor initial graft function defined by the occurrence of DGF (defined by a decrease in serum creatinine of <10%/day for 3 consecutive days after transplant) or slow graft function (serum creatinine >3 mg/dL 5 days after transplant without dialysis) (NCT01643382)
Timeframe: 7 days after transplant

Intervention	Participants (Count of Participants)
Tight Glucose Control	13
Standard Glucose Control	22

Reviews

3 reviews available for pioglitazone and Diabetes Mellitus, Type 1

Article	Year
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. The Cochrane database of systematic reviews, 2020, 07-30, Volume: 8 Topics: Adamantane; Bias; Cause of Death; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-P	2020
Alternative Agents in Type 1 Diabetes in Addition to Insulin Therapy: Metformin, Alpha-Glucosidase Inhibitors, Pioglitazone, GLP-1 Agonists, DPP-IV Inhibitors, and SGLT-2 Inhibitors. Journal of pharmacy practice, 2016, Volume: 29, Issue:2 Topics: Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glycoside Hy	2016
Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis. Diabetes research and clinical practice, 2012, Volume: 98, Issue:1 Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Pio	2012

Trials

4 trials available for pioglitazone and Diabetes Mellitus, Type 1

Article	Year
Effect of pioglitazone on the course of new-onset type 1 diabetes mellitus. Journal of clinical research in pediatric endocrinology, 2013, Volume: 5, Issue:4 Topics: Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Glycated He	2013
Pioglitazone may accelerate disease course of slowly progressive type 1 diabetes. Diabetes/metabolism research and reviews, 2011, Volume: 27, Issue:8 Topics: Adult; Age of Onset; Diabetes Mellitus, Type 1; Disease Progression; Female; Glycated Hemoglobin; Hu	2011
Pioglitazone as adjunctive therapy in adolescents with type 1 diabetes. The Journal of pediatrics, 2006, Volume: 149, Issue:6 Topics: Adolescent; Blood Glucose; Child; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Humans; Hy	2006
Effect of pioglitazone therapy in lean type 1 diabetes mellitus. Diabetes research and clinical practice, 2007, Volume: 78, Issue:3 Topics: Blood Glucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hy	2007

Other Studies

17 other studies available for pioglitazone and Diabetes Mellitus, Type 1

Article	Year
Adding SGLT2 Cotransporter Inhibitor to PPARγ Activator Does Not Provide an Additive Effect in the Management of Diabetes-Induced Vascular Dysfunction. Pharmacology, 2023, Volume: 108, Issue:6 Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Infl	2023
Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII/NF-κB/TGF-β1 and PPAR-γ signaling pathway. Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:2 Topics: Animals; Blood Glucose; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiotonic Agents; Curc	2021
Vildagliptin/pioglitazone combination improved the overall glycemic control in type I diabetic rats. Canadian journal of physiology and pharmacology, 2018, Volume: 96, Issue:8 Topics: Adamantane; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug	2018
Acquired generalised lipodystrophy and type 1 diabetes mellitus in a child: a rare and implacable association. BMJ case reports, 2018, Aug-03, Volume: 2018 Topics: Anticholesteremic Agents; Child; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Insulin; In	2018
Disseminated cryptococcosis in a diabetic patient. Cutis, 2014, Volume: 94, Issue:2 Topics: Administration, Oral; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diabetes Mellitus,	2014
Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia. Diabetic medicine : a journal of the British Diabetic Association, 2016, Volume: 33, Issue:9 Topics: Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2;	2016
Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes. Diabetes, obesity & metabolism, 2016, Volume: 18 Suppl 2 Topics: Adipose Tissue; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Blood Glu	2016
Pioglitazone might prevent the progression of slowly progressive type 1 diabetes. Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:12 Topics: Administration, Oral; Diabetes Mellitus, Type 1; Disease Progression; Humans; Hypoglycemic Agents; I	2009
Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes. Diabetes research and clinical practice, 2010, Volume: 89, Issue:1 Topics: Adiponectin; Aged; Asian People; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Dia	2010
Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures. Diabetes/metabolism research and reviews, 2011, Volume: 27, Issue:5 Topics: Accidental Falls; Bone and Bones; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellit	2011
Balancing the risks and benefits for pioglitazone in type 2 diabetes. Diabetes research and clinical practice, 2012, Volume: 98, Issue:1 Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Pio	2012
[Preventive effects of pioglitazone on diabetes and relevant mechanisms, experimental study on non-obese diabetic mice]. Zhonghua yi xue za zhi, 2004, Mar-02, Volume: 84, Issue:5 Topics: Animals; Body Weight; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Hypoglyc	2004
Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proceedings of the National Academy of Sciences of the United States of America, 2005, Jul-26, Volume: 102, Issue:30 Topics: Adipocytes; Age Factors; Amino Acid Sequence; Animals; Base Sequence; Blood Glucose; Blotting, North	2005
Thiazolidinediones may not reduce diabetes incidence in type 1 diabetes. Annals of the New York Academy of Sciences, 2006, Volume: 1079 Topics: Animals; Cyclophosphamide; Cytokines; Diabetes Mellitus, Type 1; Disease Progression; Female; Immuno	2006
Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection. Pharmacotherapy, 2007, Volume: 27, Issue:10 Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Exenatide; HIV Infections; Humans; Hypo	2007
The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dogs. Diabetes, 1997, Volume: 46, Issue:2 Topics: Animals; Biological Transport; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, T	1997
Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes. Diabetes research and clinical practice, 1999, Volume: 44, Issue:2 Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dose-Resp	1999